glp-1 news today november 2025 Pipeline Update: August - Prime Therapeutics What's next for GLP-1 innovation:

In addition, if any of our product candidates receive marketing approval, the FDA could require us to include a boxed warning in our label or adopt a risk evaluation and mitigation strategy (REMS), to ensure that the benefits outweigh its risks, which may include, among other things, a medication guide outlining the risks of the drug for distribution to patients and a communication plan to health care practitioners

Most semaglutide weight-loss prescriptions occurred late in the study period, limiting long-term follow-up data

Powerful stuff, really

It provides 12-hour moisturization to the lips to reduce their dryness and dark color

A total of 39 children were recruited, and after exclusions, 33 were randomized into two treatment groups: Oral glutathione (n=13) Transdermal glutathione (n=13) A total of 26 children completed the study